Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
24-4
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
24-4
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #117427
advertisement
Bhatta RS
36
Showing records 1 to 25 |
Display all abstracts from
Bhatta RS
118537
Pirfenidone: A Promising Drug in Ocular Therapeutics
Bisen AC
Chemistry and Biodiversity
2024; 21: e202301389
118126
Yadav KS
Journal of Ocular Pharmacology and Therapeutics
2024; 40: 309-324
118590
Polymers and their engineered analogues for ocular drug delivery: Enhancing therapeutic precision
Biswas A
Biopolymers
2024; 115: e23578
118537
Pirfenidone: A Promising Drug in Ocular Therapeutics
Bisen AC
Chemistry and Biodiversity
2024; 21: e202301389
118126
Yadav KS
Journal of Ocular Pharmacology and Therapeutics
2024; 40: 309-324
118537
Pirfenidone: A Promising Drug in Ocular Therapeutics
Bisen AC; Agrawal S
Chemistry and Biodiversity
2024; 21: e202301389
118126
Bisen AC; Bisen AC
Journal of Ocular Pharmacology and Therapeutics
2024; 40: 309-324
118590
Polymers and their engineered analogues for ocular drug delivery: Enhancing therapeutic precision
Kumar S
Biopolymers
2024; 115: e23578
118126
Bisen AC; Ishteyaque S
Journal of Ocular Pharmacology and Therapeutics
2024; 40: 309-324
118590
Polymers and their engineered analogues for ocular drug delivery: Enhancing therapeutic precision
Choudhury AD
Biopolymers
2024; 115: e23578
118537
Pirfenidone: A Promising Drug in Ocular Therapeutics
Rayiti R; Sanap SN
Chemistry and Biodiversity
2024; 21: e202301389
118590
Polymers and their engineered analogues for ocular drug delivery: Enhancing therapeutic precision
Bisen AC
Biopolymers
2024; 115: e23578
118126
Sharma I
Journal of Ocular Pharmacology and Therapeutics
2024; 40: 309-324
118537
Pirfenidone: A Promising Drug in Ocular Therapeutics
Sanap SN
Chemistry and Biodiversity
2024; 21: e202301389
118590
Polymers and their engineered analogues for ocular drug delivery: Enhancing therapeutic precision
Bisen AC
Biopolymers
2024; 115: e23578
118537
Pirfenidone: A Promising Drug in Ocular Therapeutics
Sanap SN
Chemistry and Biodiversity
2024; 21: e202301389
118590
Polymers and their engineered analogues for ocular drug delivery: Enhancing therapeutic precision
Bisen AC; Sanap SN
Biopolymers
2024; 115: e23578
118126
Verma S
Journal of Ocular Pharmacology and Therapeutics
2024; 40: 309-324
118590
Polymers and their engineered analogues for ocular drug delivery: Enhancing therapeutic precision
Sanap SN
Biopolymers
2024; 115: e23578
118537
Pirfenidone: A Promising Drug in Ocular Therapeutics
Biswas A
Chemistry and Biodiversity
2024; 21: e202301389
118590
Polymers and their engineered analogues for ocular drug delivery: Enhancing therapeutic precision
Sanap SN
Biopolymers
2024; 115: e23578
118126
Sanap SN
Journal of Ocular Pharmacology and Therapeutics
2024; 40: 309-324
118537
Pirfenidone: A Promising Drug in Ocular Therapeutics
Mishra A
Chemistry and Biodiversity
2024; 21: e202301389
118126
Sanap SN
Journal of Ocular Pharmacology and Therapeutics
2024; 40: 309-324
118590
Polymers and their engineered analogues for ocular drug delivery: Enhancing therapeutic precision
Agrawal S
Biopolymers
2024; 115: e23578
«
1
2
»
Issue
24-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept